Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Always consult with your healthcare provider before starting, stopping, or switching any weight-loss medication
GLP-1 receptor agonists mimic gut hormones to curb appetite and slow digestion, a mechanism driving the success of therapies from Novo Nordisk (Ozempic for diabetes and Wegovy for Lillys oral GLP-1 drug orforglipron achieves 12.4% weight loss in phase 3 trial but trails injectable rivals tirzepatide and retatrutide Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes
Takeaway From Testimonials These real-world stories suggest that ColonBroom GLP-1 Booster works best for individuals seeking gradual, sustainable improvements rather than dramatic, quick fixes
GLP-1 medications like Wegovy and Mounjaro are helpful tools for supporting weight management because they help to regulate appetite and food intake, leading to significant changes in body weight and overall health
Those results were in HIV patients with lipodystrophy
